©The Author(s) 2025.
World J Gastroenterol. Nov 14, 2025; 31(42): 111706
Published online Nov 14, 2025. doi: 10.3748/wjg.v31.i42.111706
Published online Nov 14, 2025. doi: 10.3748/wjg.v31.i42.111706
Figure 6 Colonic mucus of irritable bowel syndrome patients impairs intestinal barrier integrity via Thymosin β4.
Colonic mucus from healthy and irritable bowel syndrome individuals was transplanted into rats’ colon. A: Immunohistochemical images of zonulin 1 in wild-type (WT) and Tβ4−/− rats; B: TEM images of colon. Magnification: 8000 ×, Scale bar, 2 μm. Magnification: 25000 ×, Scale bar, 500 nm; C: The immunohistochemistry staining of myosin light chain kinase. Scale bar, 50 μm; D: Representative FISH staining for bacterial infiltration using EUB338 probe (red) and DAPI (blue). Scale bar, 50 μm. Tβ4: Thymosin β4; WT: Wild-type; IBS: Irritable bowel syndrome.
- Citation: Sun YS, Bai XQ, Sun KD, Li J, Liu L, Chen YY, Zeng ZY, Wang Q, Guo YB. Thymosin β4 released by mast cells under stress conditions impairs intestinal epithelial barrier via IL22RA1/JAK1/STAT3 signaling in irritable bowel syndrome. World J Gastroenterol 2025; 31(42): 111706
- URL: https://www.wjgnet.com/1007-9327/full/v31/i42/111706.htm
- DOI: https://dx.doi.org/10.3748/wjg.v31.i42.111706